Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,800,688
  • Shares Outstanding, K 94,810
  • Annual Sales, $ 16,140 K
  • Annual Income, $ -54,450 K
  • 60-Month Beta 1.51
  • Price/Sales 20.42
  • Price/Cash Flow N/A
  • Price/Book 12.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.09
  • Number of Estimates 4
  • High Estimate 0.19
  • Low Estimate 0.06
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +175.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.63 +5.97%
on 09/09/19
36.80 -20.43%
on 08/30/19
-1.91 (-6.12%)
since 08/16/19
3-Month
25.68 +14.02%
on 07/01/19
36.80 -20.43%
on 08/30/19
+1.39 (+4.98%)
since 06/18/19
52-Week
10.41 +181.27%
on 12/24/18
36.80 -20.43%
on 08/30/19
+10.44 (+55.41%)
since 09/18/18

Most Recent Stories

More News
After Yesterday's Decline of 3.45%, Arrowhead Pharma Offers Investors Better Value

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $28.52 to a high of $29.41. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of...

ARWR : 29.28 (-0.88%)
Arrowhead Pharmaceuticals Presents Initial Top-Line Clinical Data and Preclinical Data on RNAi Candidates ARO-APOC3 and ARO-ANG3

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today presented initial top-line clinical data at The Global Summit on Cardiology and Heart Diseases, being held in Dubai, UAE. The data demonstrate that,...

ARWR : 29.28 (-0.88%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (AIMT , ARWR, LJPC , MRTX, AGIO )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

AIMT : 22.77 (+1.74%)
LJPC : 10.81 (-4.59%)
ARWR : 29.28 (-0.88%)
MRTX : 91.76 (+3.99%)
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?

Style Box ETF report for FYC

IWO : 201.17 (-0.54%)
FYC : 45.63 (-0.87%)
ARWR : 29.28 (-0.88%)
LSCC : 20.34 (-3.88%)
SHAK : 101.43 (-0.08%)
VBK : 187.79 (-0.49%)
Arrowhead Pharmaceuticals to Participate in Upcoming September 2019 Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

ARWR : 29.28 (-0.88%)
Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has begun dosing in a Phase 2b study...

ARWR : 29.28 (-0.88%)
JNJ : 130.41 (+0.57%)
Cancer Drugs Projected to Generate the Most in Pharma Revenues

Cancer drug market revenues have been steadily rising in the past few years and all indicators predict that they will continue to rise over the next several years. According to industry sources, in 20118...

ARWR : 29.28 (-0.88%)
ABBV : 71.27 (-0.46%)
MNK : 2.53 (-6.64%)
NBRV : 2.26 (-3.83%)
MBRX : 1.18 (-7.09%)
Arrowhead Pharmaceuticals Doses First Patient in SEQUOIA Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has dosed the first patient in SEQUOIA (AROAAT2001), a potentially pivotal Phase 2/3 clinical study of ARO-AAT, the company's second...

ARWR : 29.28 (-0.88%)
Shares of ARWR Up 100.0% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Arrowhead Pharma (NASDAQ:ARWR) on January 8th, 2019 at $14.17. In approximately 7 months, Arrowhead Pharma has returned 100.00% as of today's recent price of $28.33....

ARWR : 29.28 (-0.88%)
Arrowhead Pharmaceuticals Reports Fiscal 2019 Third Quarter Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2019 third quarter ended June 30, 2019. The company is hosting a conference call at 4:30 p.m. EDT to discuss...

ARWR : 29.28 (-0.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade ARWR with:

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

2nd Resistance Point 30.35
1st Resistance Point 29.82
Last Price 29.28
1st Support Level 28.60
2nd Support Level 27.91

See More

52-Week High 36.80
Last Price 29.28
Fibonacci 61.8% 26.72
Fibonacci 50% 23.60
Fibonacci 38.2% 20.49
52-Week Low 10.41

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar